Ameliorative effect of selenium nanoparticles on testicular toxicity induced by cisplatin in adult male rats
Copyright © 2023 Elsevier Ltd. All rights reserved..
Cisplatin (Cis) is a treatment for testicular germ-cell tumors (TGCTs). Unfortunately, it causes testicular toxicity due to releasing reactive oxygen species (ROS) causing damage to testicular cells and chromosomes. The current study aimed to investigate the ameliorative effect of selenium nanoparticles (SeNPs) against cisplatin testicular toxicity in male rats by assessment of body weight, testis weight, oxidative stress markers in testis homogenates as (malondialdehyde (MDA), Superoxide dismutase (SOD), Glutathione reduced (GSH), Glutathione peroxidase (GSH ∼ PX) and Catalase (CAT)), gene expression, testosterone concentration (T), sperm characteristics (count, motility and abnormality) and testicular histopathology. Methods: Thirty adult male rats divided equally into four groups; a single dose intraperitoneally injection of cisplatin (10 mg/kg) and selenium nanoparticles (2 mg/kg/day) were administrated alone or in combination. Cis group showed a decrease in body weight, testis weight, antioxidant activities (SOD, GSH, GSH ∼ PX and CAT), T concentration and steroidogenetic expression, the data recorded an increase in MDA levels and sperm abnormality, meanwhile histopathology of testis sections showed degenerative changes in the seminiferous tubules. The co-administration of selenium nanoparticles ameliorated the harmful effects of cisplatin. In conclusion; SeNPs through its antioxidant potential may be useful to prevent the testicular toxicity induced by cisplatin to the rat testis by reducing oxidative stress.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:179 |
---|---|
Enthalten in: |
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association - 179(2023) vom: 01. Sept., Seite 113979 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Keshta, Akaber T [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antioxidants |
---|
Anmerkungen: |
Date Completed 07.09.2023 Date Revised 07.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.fct.2023.113979 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360441483 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360441483 | ||
003 | DE-627 | ||
005 | 20231226083024.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.fct.2023.113979 |2 doi | |
028 | 5 | 2 | |a pubmed24n1201.xml |
035 | |a (DE-627)NLM360441483 | ||
035 | |a (NLM)37544473 | ||
035 | |a (PII)S0278-6915(23)00381-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Keshta, Akaber T |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ameliorative effect of selenium nanoparticles on testicular toxicity induced by cisplatin in adult male rats |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.09.2023 | ||
500 | |a Date Revised 07.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Ltd. All rights reserved. | ||
520 | |a Cisplatin (Cis) is a treatment for testicular germ-cell tumors (TGCTs). Unfortunately, it causes testicular toxicity due to releasing reactive oxygen species (ROS) causing damage to testicular cells and chromosomes. The current study aimed to investigate the ameliorative effect of selenium nanoparticles (SeNPs) against cisplatin testicular toxicity in male rats by assessment of body weight, testis weight, oxidative stress markers in testis homogenates as (malondialdehyde (MDA), Superoxide dismutase (SOD), Glutathione reduced (GSH), Glutathione peroxidase (GSH ∼ PX) and Catalase (CAT)), gene expression, testosterone concentration (T), sperm characteristics (count, motility and abnormality) and testicular histopathology. Methods: Thirty adult male rats divided equally into four groups; a single dose intraperitoneally injection of cisplatin (10 mg/kg) and selenium nanoparticles (2 mg/kg/day) were administrated alone or in combination. Cis group showed a decrease in body weight, testis weight, antioxidant activities (SOD, GSH, GSH ∼ PX and CAT), T concentration and steroidogenetic expression, the data recorded an increase in MDA levels and sperm abnormality, meanwhile histopathology of testis sections showed degenerative changes in the seminiferous tubules. The co-administration of selenium nanoparticles ameliorated the harmful effects of cisplatin. In conclusion; SeNPs through its antioxidant potential may be useful to prevent the testicular toxicity induced by cisplatin to the rat testis by reducing oxidative stress | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antioxidants | |
650 | 4 | |a Cisplatin | |
650 | 4 | |a Peroxynitrite | |
650 | 4 | |a Selenium nanoparticles | |
650 | 4 | |a Testicular toxicity | |
650 | 7 | |a Cisplatin |2 NLM | |
650 | 7 | |a Q20Q21Q62J |2 NLM | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Selenium |2 NLM | |
650 | 7 | |a H6241UJ22B |2 NLM | |
650 | 7 | |a Glutathione |2 NLM | |
650 | 7 | |a GAN16C9B8O |2 NLM | |
650 | 7 | |a Superoxide Dismutase |2 NLM | |
650 | 7 | |a EC 1.15.1.1 |2 NLM | |
700 | 1 | |a Fathallah, Ahmed M |e verfasserin |4 aut | |
700 | 1 | |a Attia, Yasser A |e verfasserin |4 aut | |
700 | 1 | |a Salem, Emad A |e verfasserin |4 aut | |
700 | 1 | |a Watad, Shimaa H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association |d 1982 |g 179(2023) vom: 01. Sept., Seite 113979 |w (DE-627)NLM012624691 |x 1873-6351 |7 nnns |
773 | 1 | 8 | |g volume:179 |g year:2023 |g day:01 |g month:09 |g pages:113979 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.fct.2023.113979 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 179 |j 2023 |b 01 |c 09 |h 113979 |